Abcellera Biologics Inc
NASDAQ:ABCL

Watchlist Manager
Abcellera Biologics Inc Logo
Abcellera Biologics Inc
NASDAQ:ABCL
Watchlist
Price: 2.63 USD -3.31%
Market Cap: 775m USD
Have any thoughts about
Abcellera Biologics Inc?
Write Note

Operating Margin
Abcellera Biologics Inc

-934.6%
Current
-247%
Average
3.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-934.6%
=
Operating Profit
-308.1m
/
Revenue
33m

Operating Margin Across Competitors

Country CA
Market Cap 773.6m USD
Operating Margin
-935%
Country US
Market Cap 1.4T USD
Operating Margin
14%
Country US
Market Cap 211.3B USD
Operating Margin
17%
Country US
Market Cap 177.6B USD
Operating Margin
21%
Country KR
Market Cap 71.2T KRW
Operating Margin
31%
Country CH
Market Cap 39.5B CHF
Operating Margin
13%
Country US
Market Cap 39.8B USD
Operating Margin
14%
Country US
Market Cap 39.3B USD
Operating Margin
25%
Country US
Market Cap 27.8B USD
Operating Margin
28%
Country US
Market Cap 24.1B USD
Operating Margin
7%
Country US
Market Cap 23.5B USD
Operating Margin
20%

Profitability Report

View the profitability report to see the full profitability analysis for Abcellera Biologics Inc.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-934.6%
=
Operating Profit
-308.1m
/
Revenue
33m
What is the Operating Margin of Abcellera Biologics Inc?

Based on Abcellera Biologics Inc's most recent financial statements, the company has Operating Margin of -934.6%.